NCT01366144 2026-04-13
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
Phase 1 Active not recruiting
Clinical Trials
11 trialsNCT01022476 2026-04-06
LIVERAL
ANRS, Emerging Infectious Diseases
Phase 1/2 Completed
NCT04618692 2025-12-18
Biliary Anastomosis Using Surgical Loupe Versus Microscope in Living Donor Liver Transplantation
Istanbul Medipol University Hospital
Phase NA Completed
NCT07053488 2025-07-08
CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
Phase 1/2 Recruiting
NCT05484908 2024-11-29
Efficacy and Safety of ALSS Treatment for ICIs-LF in Patients With HCC
Third Affiliated Hospital, Sun Yat-Sen University
Phase NA Recruiting
NCT03908255 2022-01-28
BCAA in HCC
Louisiana State University Health Sciences Center in New Orleans
Phase 2 Withdrawn
NCT04107324 2021-01-15
ARAPS
University of Aarhus
Phase NA Unknown
NCT02635347 2019-08-20
Remote Ischemic Conditioning (RIC) in Recipients of Brain Death Donor Livers - A Feasibility and Safety Study
Rutgers, The State University of New Jersey
Phase NA Completed
NCT01643447 2016-03-31
Ulinastatin Preventing Postoperative Hepatic Failure in Hepatocellular Carcinoma (HCC)
Eastern Hepatobiliary Surgery Hospital
Phase NA Completed
NCT01394497 2013-02-18
Use of N-Acetylcysteine During Liver Procurement
Azienda Ospedaliera di Padova
Phase 2 Completed
NCT01423708 2012-07-18
EPOCAL
Azienda Ospedaliera di Padova
Phase 2 Unknown